NEW ORLEANS -- In an interview at the Society of Nuclear Medicine and Molecular Imaging annual meeting, Phillip Kuo, MD, PhD, of the City of Hope in Duarte, CA, discussed new appropriate use criteria for amyloid and tau PET imaging in Alzheimer’s disease patients.
Video from SNMMI: Phillip Kuo on new Alzheimer’s disease imaging guidelines
Latest in Molecular Imaging
Theranostic pair ready for testing in lung cancer
January 8, 2026
Archeus Technologies names new slate of executives
January 7, 2026
Shine completes Lantheus SPECT acquisition, names CEO
January 2, 2026




















